Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Expected Growth Rate of the Cell Viability Assays Market Based on Industry Projections?

In recent times, the market size for cell viability assays has experienced a significant surge. Projected growth sees it escalating from $1.56 billion in 2024 to $1.73 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. Various factors have contributed to historical growth, including increased funding for cancer research, a rise in pharmaceutical R&D expenses, expansion in the biotech sector, advancements in cell culture methodologies, a heightened demand for stem cell research, an increased necessity for toxicity testing, a surge in the usage of real-time cell analysis systems, and an increase in the quantity of contract research organizations (CROs).

Expectations for the cell viability assays market size foresee a quickened expansion in the coming years. Its value is projected to reach $2.58 billion by 2029 with a compound annual growth rate (CAGR) of 10.5%. Various factors contributing to growth during the prediction period include the rising requirement for tailor-made medicine, augmented government support for cell-based research, an amplified emphasis on precision medicine, advancements in stem cell research and utilization, the increase in automated cell viability analyzers, growing instances of infectious diseases, a heightened interest in enhancing assay accuracy and sensitivity, increased consciousness about cell viability assays benefits, and enhancement in organ on a chip technology development. The expected trends for this period encompass advancements in high throughput screening techniques, the application of AI and machine learning algorithms, the emergence of real-time monitoring systems, incorporation of automated liquid handling systems, the creation of multiplex assays for simultaneous cell viability measurement, use of more sustainable and eco-conscious reagents, the introduction of user-friendly assay kits, enhancements in electrochemical assays, the application of scalable cell viability assays, as well as the development of assays compatible with primary cells and stem cells.

What Key Drivers Are Accelerating the Growth of the Cell Viability Assays Market During the Forecast Period?

The rise in cell-based therapeutics is anticipated to boost the cell viability assay market’s advancement. Cell-based therapeutics entail the use of live cells to repair or replace damaged tissue, tackle diseases, or restore regular function. The surge in these therapies is propelled by advancements in biotechnology, rising investments in regenerative medicine, growing acceptance and adoption of cell therapies, as well as enhancements in cell engineering and production technologies. In order to optimize treatment efficacy and quality control, cell viability assays are necessary for ensuring the health, functionality, and safety of therapeutic cells. For example, the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization based in the US, reported that 38 trials commenced for non-genetically modified cell therapies in Q1 2023, an increase of 7 from Q4 2022. As such, the expansion of cell-based therapeutics is fuelling the growth of the cell viability assay market.

Get Your Free Sample of the Global Cell Viability Assays Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Companies Are At the Forefront of Innovation in the Cell Viability Assays Market?

Major companies operating in the cell viability assays market are:

• Thermo Fisher Scientific Inc.

• Danaher Corporation

• Merck KGaA

• Becton

• Dickinson

How Are Emerging Trends in Consumer Behavior Affecting the Cell Viability Assays Market?

Leading businesses in the cell viability assays market are introducing advanced cell screening techniques to boost precision and expedite the process of drug discovery. These technologies augment cell viability assays by facilitating a swift, precise, and high-throughput evaluation of cell health and responses, thereby refining experimental parameters and aiding in the formulation of superior therapeutic strategies. For instance, in May 2024, the technology firm based in Germany, Arralyze, launched CellShepherd, a state-of-the-art platform for single-cell analysis. This platform employs exclusive nanowell glass arrays to shrink cell-based assays for real-time monitoring. The self-reliant system provides accurate cell dispensing, co-culturing in sterile environments, and imaging via both brightfield and fluorescent channels. The platform’s AI-powered analysis ensures precise cell counting and tracking. This easy-to-use platform addresses the growing demand for accurate single-cell research in life science and biomedical domains.

Get Instant Access to the Global Cell Viability Assays Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Key Segments of the Cell Viability Assays Market Are Poised for Growth and Innovation?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Regions Are Propelling Growth in the Cell Viability Assays Industry?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Cell Viability Assays Market’s Scope?

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Stem Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: